Berkshire may have repurchased roughly $8.5 billion of its own stock from April 15 through July 14, according to UBS.
Gulf uncertainty is creating ‘win, win’ strategy with Chevron and other oil majors
With options premiums still elevated due to the military conflict in the Gulf, selling puts on an energy major posting record free cash flow offers a rare opportunity.
Applied Materials is about to report earnings. How to trade the AI picks-and-shovels play ahead of results
Even as the stock has more than doubled in 2026, the outlook is still strong for the wafer fab equipment giant.
SpaceX shares upgraded. Argus says AI investments will pay off, and don’t bet against Musk
SpaceX could continue to bounce back as investments in artificial intelligence begin to pay off, according to Argus.
Shares of this digital medical platform were up more than 100% at one point. Here’s what’s driving it
The company is seeing huge profitability potential and a larger addressable market as a result of AI search.
JPMorgan upgrades Etsy, sees turnaround story taking stock another 20% higher
Etsy reported strong sales growth during its second-quarter earnings report this week, which could give its stock more room to run, per JPMorgan.
Citi downgrades airline stock to ‘sell’ worries about leisure travel
Citi downgraded JetBlue Airways to sell from hold, citing headwinds for leisure travel, among other challenges for the airline stock.
Friday’s big stock stories: What’s likely to move the market in the next trading session
The Dow Industrials snapped a five-day winning streak on Thursday and the S&P 500 notched back-to-back losses as oil prices rose.
SpaceX shares passed a key test Thursday. Now sophisticated traders are betting the bottom may be in
Shares of Elon Musk’s rocket company were trading higher in Thursday’s session even as a key lock-up provision expired.
This building materials stock has a favorable setup and a breakout could be in the cards, charts show
Owens Corning lacks the volatile ride of a tech stock, but it has a risk/reward potential that patient investors should crave.